Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Human milk oligosaccharides quell IBS symptoms

Publish date:: December 20, 2019

Key clinical point: Oral human milk oligosaccharides improve irritable bowel syndrome symptoms.

Major finding: After 4 weeks of taking a blend of oral human milk oligosaccharides, 77% of patients with irritable bowel syndrome reported a significant reduction in symptom severity.

Study details: This was a 12-week, open-label, uncontrolled study of 317 patients with irritable bowel syndrome at 17 U.S. sites.

Disclosures: The presenter reported serving on an advisory board for Glycom, the Danish company which sponsored the study.

Citation:

Simren M. ACG 2019, Abstract 43.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

IBD patients prefer vedolizumab over anti-TNF drugs,

During pandemic, many gastroenterologists report low resilience, insomnia,

Upper GI bleeds in COVID-19 not related to increased mortality,